E-Updates

E-Updates in Lung Cancer: Controversies and Challenges, Volume 3
Second-Line Therapy and Beyond in the Changing Landscape
December 2009
Treatment Paradigms in Advanced Non-Small-Cell Lung Cancer: The Evolving Role of Maintenance Therapy
September 2009
mAbs and EGFR TKI in Lung Cancer: The Front-Line Setting
August 2009


E-Updates in Ovarian Cancer
Part 1: Novel Investigational Agents in Primary and Recurrent Ovarian Cancer
Part 2: The Current Role of Maintenance in the Treatment of Ovarian Cancer
December 2009
Part 1: Overview of Current Challenges in Front-line Treatment of Ovarian Cancer
Part 2: Treatment Standards in Platinum-Sensitive Recurrent Ovarian Cancer
November 2009


E-Updates in HER2 Targeting in Breast Cancer, Volume 3
Part 1: Advances in Our Understanding of Trastuzumab
Part 2: An Update on Adjuvant Therapy with Trastuzumab
Part 3: An Update on the Use of Lapatinib
Part 4: New Drugs for HER2-Positive Metastatic Breast Cancer: Trastuzumab-DM1, Neratinib, and Tanespimycin
November 2009


E-Updates in the Adjuvant Treatment of Breast Cancer; Volume 2
Updates on Hormonal Therapies
October 2009
Updates on Chemotherapeutic Options and Targeted Therapies
September 2009


E-Updates: Updates in Liver-Limited Disease
Surgical Approach to Liver-Limited Metastatic Colorectal Cancer
September 2009
Issues Relating to Cytotoxic and Biologic Agents in Liver-Limited Disease
August 2009


E-Updates in Rectal Cancer: Controversies in the Treatment of Rectal Cancer
Part 1: Is Local Excision Appropriate?
September 2009
Part 2: Are 3D or IMRT Techniques Helpful?
September 2009


Part 1: Controversies in Preoperative Chemoradiation for Rectal Cancer
May 2009
Part 2: Are Novel Chemoradiation Regimens More Effective?
May 2009